Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastric intestinal metaplasia: progress and remaining challenges
Qi-Yue Tong1,2, Min-Jiao Pang1,2, Xiao-Hai Hu1,2
1Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, 155 N. Nanjing Street, Shenyang, 110001, Liaoning, China.
Gastric intestinal metaplasia (GIM) is a precancerous condition linked to chronic inflammation. Understanding GIM mechanisms is crucial for preventing gastric cancer, but progress is hindered by a lack of effective animal models.
Area of Science:
- Gastroenterology and Oncology
- Cellular and Molecular Biology
- Pathology
Background:
- Chronic inflammation alters gastric gland organization, leading to parietal cell loss and metaplasia.
- While atrophy and pyloric metaplasia are understood, mechanisms of intestinal metaplasia in chronic atrophic gastritis remain unclear.
- A significant gap exists in understanding gastric intestinal metaplasia (GIM) due to limited small animal models.
Purpose of the Study:
- To review the current research on gastric intestinal metaplasia (GIM) and its role in gastric tumorigenesis.
- To explore histological subtypes of GIM, their association with tumor formation, and current biomarkers.
- To survey existing mouse models for GIM and discuss potential cell lineages and signaling pathways involved.
Main Methods:
- Comprehensive literature review of GIM research.
- Analysis of histological subtypes and their link to gastric cancer.
- Survey of available mouse models and discussion of cell lineages and signaling pathways.
Main Results:
- GIM is a key precancerous lesion in gastric carcinogenesis.
- Histological subtypes of GIM show varying associations with tumor risk.
- Limited mouse models exist, hindering mechanistic studies of GIM development and signaling pathways.
Conclusions:
- Further research into GIM mechanisms, aided by better animal models, is essential for gastric cancer prevention.
- Understanding the cell lineages and signaling pathways in GIM can lead to targeted therapeutic strategies.
- GIM represents a critical precancerous stage requiring focused investigation for early detection and treatment.
Related Concept Videos
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
What is Monogastric Digestion?
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...

